| GTO ID | GTC2543 |
| Trial ID | NCT04677088 |
| Disease | Recurrent Hepatocellular Carcinoma |
| Altered gene | HBV gene |
| Therapeutic/Target gene | Target gene |
| Therapy | TCR-T cell |
| Treatment | HBV TCR-T cells |
| HLA | HLA class I |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Phase I Study of T Cell Receptor-Redirected T Cells With Recurrent HBV Treatment in Patients-Related Hepatocellular Carcinoma in Post Liver Transplantation |
| Year | 2020 |
| Country | China |
| Company sponsor | Xiaoshun He |
| Other ID(s) | LTCR-HCC-2-2 |
| Cohort 1 | |||||||||||
|
|||||||||||